Stocktoria

DEXCOM INC DXCM

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2005-04-14 · LEI

DEXCOM INC statistics & valuation

P / E32.4×
P / S5.8×
P / B9.9×
P / FCF25.1×
Net margin17.9%
FCF margin23.1%
Return on capital21.7%
Graham number -80.3%$17.85

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($17.85); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
-11.40% -7.00% -12.30% 6.80% 28.50% 8.90% 11.70% 14.90% 14.30% 17.90% 2016201720182019202020212022202320242025
Gross margin (%)
66.00% 68.50% 64.40% 63.10% 66.40% 68.60% 64.70% 63.20% 60.50% 60.10% 2016201720182019202020212022202320242025
Operating margin (%)
-11.10% -5.90% -18.10% 9.60% 15.50% 10.90% 13.40% 16.50% 14.90% 19.60% 2016201720182019202020212022202320242025
Return on equity (%)
-23.10% -12.00% -19.20% 11.50% 30.10% 10.60% 16.00% 26.20% 27.40% 30.50% 2016201720182019202020212022202320242025
Shares outstanding
338.4M 348.0M 360.0M 369.2M 420.4M 428.8M 427.5M 425.5M 412.7M 405.5M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-16.30% -5.60% -6.60% 4.20% 12.80% 4.40% 6.30% 8.60% 8.90% 13.20% 2016201720182019202020212022202320242025
Free cash flow margin (%)
0.10% 3.60% 5.40% 9.10% 14.40% 2.20% 10.50% 14.10% 15.60% 23.10% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$0.14 -$0.36 $0.28 $1.33 $0.53 $0.82 $1.30 $1.42 $2.09 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

DEXCOM INC trades at about 43.4× earnings — below its 10-year norm (10-year range 34.9×–218.9×, median 93.3×).

34.9× 218.9×

Shaded band = 10-year range (34.9×–218.9×); dot = today's 43.4×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin60.1%60.5%63.2%64.7%68.6%66.4%63.1%64.4%68.5%66.0%
Operating margin19.6%14.9%16.5%13.4%10.9%15.5%9.6%-18.1%-5.9%-11.1%
Net margin17.9%14.3%14.9%11.7%8.9%28.5%6.8%-12.3%-7.0%-11.4%
FCF margin23.1%15.6%14.1%10.5%2.2%14.4%9.1%5.4%3.6%0.1%
Return on assets13.2%8.9%8.6%6.3%4.4%12.8%4.2%-6.6%-5.6%-16.3%
Return on equity30.5%27.4%26.2%16.0%10.6%30.1%11.5%-19.2%-12.0%-23.1%
Current ratio1.881.472.841.995.115.585.477.645.362.73

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.